Junryo Rii

Chiba, 2608670, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Genetic and clinical characteristics of Japanese cystinuria with exon and exon-intron boundary variants.

Genetic and clinical characteristics of Japanese cystinuria with exon and exon-intron boundary variants.

Journal: Scientific reports
Published: August 10, 2024

Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgery.

Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgery.

Journal: Scientific reports
Published: February 25, 2024

Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer.

Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer.

Journal: Anticancer research
Published: October 18, 2023

The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.

The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.

Journal: Cancer science
Published: October 12, 2023

Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.

Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.

Journal: The Prostate
Published: July 06, 2023

L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.

L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.

Journal: Cancer science
Published: May 25, 2023

Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy.

Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy.

Journal: Scientific reports
Published: January 27, 2023

Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.

Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.

Journal: Cancers
Published: November 05, 2022

Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients.

Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients.

Journal: Prostate international
Published: May 05, 2021

Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.

Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.

Journal: Cancer science
Published: January 18, 2021

Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.

Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.

Journal: The Prostate
Published: February 07, 2020

Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.

Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.

Journal: The Prostate
Published: December 09, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026